Evaxion A (EVAX) EBT Growth (3y) (2023 - 2026)
Evaxion A (EVAX) EBT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 32.96% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 28.95% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -49.71% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 20.92% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 12.01% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -1.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.92% |
| Dec 31, 2025 | 39.54% |
| Sep 30, 2025 | 54.80% |
| Jun 30, 2025 | -0.54% |
| Mar 31, 2025 | 33.55% |
| Dec 31, 2024 | 17.87% |
| Sep 30, 2024 | 29.00% |
| Jun 30, 2024 | 5.11% |
| Mar 31, 2024 | 30.39% |
| Dec 31, 2023 | 0.51% |
| Sep 30, 2023 | -8.57% |
| Jun 30, 2023 | -14.50% |
| Mar 31, 2023 | -25.20% |